Bioventus Return On Equity vs. Return On Asset

BVS Stock  USD 6.69  0.09  1.33%   
Based on Bioventus' profitability indicators, Bioventus' profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Bioventus' ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.90)
Current Value
(0.85)
Quarterly Volatility
0.32390038
 
Credit Downgrade
 
Yuan Drop
 
Covid
Price To Sales Ratio is likely to drop to 0.61 in 2024. Days Sales Outstanding is likely to drop to 71.47 in 2024. At this time, Bioventus' Accumulated Other Comprehensive Income is comparatively stable compared to the past year. Operating Income is likely to gain to about 16.8 M in 2024, despite the fact that Total Other Income Expense Net is likely to grow to (130.3 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.770.6233
Fairly Up
Very volatile
For Bioventus profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bioventus to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bioventus utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bioventus's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bioventus over time as well as its relative position and ranking within its peers.
  

Bioventus' Revenue Breakdown by Earning Segment

Check out Trending Equities.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.
Is Bioventus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.36)
Revenue Per Share
8.303
Quarterly Revenue Growth
0.087
Return On Assets
0.0152
Return On Equity
(0.12)
The market value of Bioventus is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus' value that differs from its market value or its book value, called intrinsic value, which is Bioventus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus' market value can be influenced by many factors that don't directly affect Bioventus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioventus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioventus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bioventus Return On Asset vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bioventus's current stock value. Our valuation model uses many indicators to compare Bioventus value to that of its competitors to determine the firm's financial worth.
Bioventus is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . At this time, Bioventus' Return On Equity is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Bioventus by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bioventus' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioventus' earnings, one of the primary drivers of an investment's value.

Bioventus' Earnings Breakdown by Geography

Bioventus Return On Asset vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Bioventus

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.12
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Bioventus

Return On Asset

 = 

Net Income

Total Assets

 = 
0.0152
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Bioventus Return On Asset Comparison

Bioventus is currently under evaluation in return on asset category among related companies.

Bioventus Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bioventus, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bioventus will eventually generate negative long term returns. The profitability progress is the general direction of Bioventus' change in net profit over the period of time. It can combine multiple indicators of Bioventus, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income794 K833.7 K
Operating Income16 M16.8 M
Income Before Tax-121.1 M-115.1 M
Total Other Income Expense Net-137.1 M-130.3 M
Net Loss-96.7 M-91.9 M
Income Tax Expense85 K80.8 K
Net Income Applicable To Common Shares22.3 M23.4 M
Net Interest Income-51.6 M-49 M
Net Loss-203.8 M-193.6 M
Non Operating Income Net Other-3 M-3.1 M
Change To Netincome10.7 M18.1 M
Net Loss(2.49)(2.37)
Income Quality(0.16)(0.15)
Net Income Per E B T 1.29  1.35 

Bioventus Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bioventus. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bioventus position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bioventus' important profitability drivers and their relationship over time.

Use Bioventus in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioventus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioventus will appreciate offsetting losses from the drop in the long position's value.

Bioventus Pair Trading

Bioventus Pair Trading Analysis

The ability to find closely correlated positions to Bioventus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioventus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioventus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioventus to buy it.
The correlation of Bioventus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioventus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioventus moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioventus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bioventus position

In addition to having Bioventus in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Baby Boomer Prospects Thematic Idea Now

Baby Boomer Prospects
Baby Boomer Prospects Theme
Equities with large market capitalization that account for significant contribution to overall economic growth especially within dividend-paying instruments and stocks from healthcare and financial sectors. The Baby Boomer Prospects theme has 98 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Baby Boomer Prospects Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Bioventus is a strong investment it is important to analyze Bioventus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bioventus' future performance. For an informed investment choice regarding Bioventus Stock, refer to the following important reports:
Check out Trending Equities.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Bioventus Stock analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
To fully project Bioventus' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bioventus at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bioventus' income statement, its balance sheet, and the statement of cash flows.
Potential Bioventus investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Bioventus investors may work on each financial statement separately, they are all related. The changes in Bioventus's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bioventus's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.